FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
Report finds PBMs charge significant markups for cancer, HIV, and other critical specialty generic drugs
Report finds PBMs charge significant markups for cancer, HIV, and other critical specialty generic drugs